California NeuroAIDS Tissue Network
加州神经艾滋病组织网络
基本信息
- 批准号:8540465
- 负责人:
- 金额:$ 119.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS neuropathyAcquired Immunodeficiency SyndromeAddressAge-YearsAgingAliquotAnti-Retroviral AgentsAntiviral AgentsAutopsyBrainCaliforniaCessation of lifeCollaborationsCollectionCommunitiesCountyDataData QualityDiseaseEnrollmentEnsureEpidemicFundingHIVHighly Active Antiretroviral TherapyHourIndividualInternationalLifeLinkLiquid substanceMedical centerMethodsNeurocognitiveNeurologicNeuropsychologyParticipantPathologicPersonsPlasmaPositioning AttributePrincipal InvestigatorProtocols documentationPsychiatryQualifyingRecruitment ActivityResearchResearch PersonnelResourcesRiskSerumSiteSpecimenTechnical ExpertiseTissue BankingTissue BanksTissue SampleTissuesUnited States National Institutes of HealthWorkclinical research sitecohortfollow-uphuman old age (65+)meetingsneurobehavioralneuropathologyneuropsychologicalpublic health relevancequality assuranceresponsesuccess
项目摘要
DESCRIPTION (provided by applicant): This is a renewal application for the California NeuroAIDS Tissue Network (CNTN) in response to the RFA- MH-13-070. The overarching objective of the CNTN remains the same today as it was when it was first established in 1998: to serve as a tissue bank resource comprised of CNS autopsy material from HIV- infected individuals who are well characterized neuropsychological and neuromedically in life. The CNTN has been very successful in meeting this primary objective. To date, we have enrolled a total of 821 participants, including 303 autopsies, 39,600 aliquots of plasma, 27,500 aliquots of CSF, 18,700 aliquots of serum, and 5,600 aliquots of PBMCs. For the current application, we are restructuring our cohort to best target and obtain autopsies from high priority cases that are aligned with the three thematic priorities identified in the RFA: a) HIV eradication from CNS reservoirs; b) mechanisms of HIV-associated neurocognitive disorders (HAND) in the setting of long term HAART, and c) HIV and aging. Specifically, we will target continuation of HIV+ participants who 1) are at greatest risk for death, 2) have been on ART for more than 10 years, and are greater than 50 years of age, which will provide valuable cases to the NNTC resource that are aligned with the NIH three thematic priorities. Specifically, we will recruit a cohort of 4 older (65+ years old) participants from a new collaboration with the Eisenhower Medical Center (EMC) in Palm Springs given that more than 10% H1V+ persons in Riverside County are 65,or older. CNTN is an active participant in the National NeuroAIDS Tissue Consortium (NNTC), a partnership of four NIH-funded neuroAIDS tissue banks. CNTN contributes to the NNTC by: 1) leading the NNTC Neuropsychology and Psychiatry subcommittee and overseeing quality assurance for these data, 2) guiding the methods for historical antiretroviral collection, 3) contributing to the refinement of the common NNTC assessment and neuropathology protocols, 4) providing review and fulfillment of NNTC-wide tissue and sample requests, and 5) serving on the NNTC Steering Committee.. The CNTN will work closely with the NNTC to ensure continued success of this exceptional national and international resource for research on neuroAIDS.
描述(由申请人提供):这是加州NeuroAIDS组织网络(CNTN)的更新申请,以响应RFA- MH-13-070。CNTN的总体目标今天仍然与1998年首次成立时相同:作为组织库资源,由生活中具有良好神经心理学和神经医学特征的HIV感染者的CNS尸检材料组成。全国营养委员会在实现这一主要目标方面非常成功。迄今为止,我们共招募了821名参与者,包括303例尸检、39,600等份血浆、27,500等份CSF、18,700等份血清和5,600等份PBMC。对于当前的应用,我们正在重组我们的队列,以达到最佳目标,并从与RFA中确定的三个主题优先级一致的高优先级病例中获得尸检结果:a)从CNS储库中根除HIV; B)在长期HAART背景下HIV相关神经认知障碍(HAND)的机制,以及c)HIV和衰老。具体而言,我们将针对以下HIV+参与者的延续:1)死亡风险最高,2)已接受ART超过10年,年龄超过50岁,这将为NNTC资源提供与NIH三个主题优先事项一致的宝贵病例。具体而言,我们将从与棕榈泉艾森豪威尔医疗中心(EMC)的新合作中招募4名老年(65岁以上)参与者,因为滨江县超过10%的H1 V+患者年龄在65岁或以上。CNTN是国家神经艾滋病组织联盟(NNTC)的积极参与者,NNTC是四个NIH资助的神经艾滋病组织库的伙伴关系。CNTN通过以下方式为NNTC做出贡献:1)领导NNTC神经心理学和精神病学小组委员会并监督这些数据的质量保证,2)指导历史抗逆转录病毒收集的方法,3)促进改进通用NNTC评估和神经病理学方案,4)审查和满足NNTC范围内的组织和样本请求,以及5)在NNTC指导委员会任职。CNTN将与NNTC密切合作,以确保这一特殊的国家和国际资源在神经艾滋病研究方面继续取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IGOR GRANT其他文献
IGOR GRANT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IGOR GRANT', 18)}}的其他基金
Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living with HIV
阻塞性睡眠呼吸暂停的内型及其对艾滋病毒感染者表型的影响
- 批准号:
10155554 - 财政年份:2018
- 资助金额:
$ 119.59万 - 项目类别:
Heroin abstinence induced HPA & SAM dysregulation disrupts HIV virologic control
海洛因戒断诱发 HPA
- 批准号:
8616999 - 财政年份:2014
- 资助金额:
$ 119.59万 - 项目类别:
Heroin abstinence induced HPA & SAM dysregulation disrupts HIV virologic control
海洛因戒断诱发 HPA
- 批准号:
8871706 - 财政年份:2014
- 资助金额:
$ 119.59万 - 项目类别:
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER) EXTENSION
CNS HIV 抗逆转录病毒治疗效果研究(章程)扩展
- 批准号:
8737536 - 财政年份:2010
- 资助金额:
$ 119.59万 - 项目类别:
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER) EXTENSION
CNS HIV 抗逆转录病毒治疗效果研究(章程)扩展
- 批准号:
8910507 - 财政年份:2010
- 资助金额:
$ 119.59万 - 项目类别:
CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) as a Resource
CNS HIV 抗逆转录病毒治疗效果研究 (CHARTER) 作为资源
- 批准号:
8163758 - 财政年份:2010
- 资助金额:
$ 119.59万 - 项目类别:
CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) as a Resource
CNS HIV 抗逆转录病毒治疗效果研究 (CHARTER) 作为资源
- 批准号:
8540327 - 财政年份:2010
- 资助金额:
$ 119.59万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 119.59万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 119.59万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 119.59万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 119.59万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 119.59万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 119.59万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 119.59万 - 项目类别:














{{item.name}}会员




